Does UBLITUXIMAB Cause Covid-19? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Covid-19 have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 2.5% of all adverse event reports for UBLITUXIMAB.
39
Reports of Covid-19 with UBLITUXIMAB
2.5%
of all UBLITUXIMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Covid-19 From UBLITUXIMAB?
Of the 39 reports, 1 (2.6%) resulted in death, 11 (28.2%) required hospitalization.
Is Covid-19 Listed in the Official Label?
Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for UBLITUXIMAB.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which UBLITUXIMAB Alternatives Have Lower Covid-19 Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM